Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 12/20 | 0.38 |
| ▸ | CTSB | P07858 | 11/20 | 0.38 |
| ▸ | CTSS | P25774 | 11/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4573200 | 0.81 | CTSK (0.57) | CTSKCTSBCTSSKCNH2HRH3 | |
| SCHEMBL4589748 | 0.79 | CTSB (0.54) | CTSKCTSBCTSSKCNH2HRH3 | |
| SCHEMBL4573253 | 0.78 | CTSK (0.39) | CTSKCTSBCTSSKCNH2MEN1 | |
| SCHEMBL4573950 | 0.78 | CTSS (0.45) | CTSKCTSBCTSSKCNH2KMT2A | |
| SCHEMBL4586118 | 0.77 | CTSB (0.42) | CTSKCTSBCTSSKCNH2 | |
| SCHEMBL8113028 | 0.75 | CTSB (0.69) | CTSKCTSBCTSSKCNH2 | |
| SCHEMBL4573939 | 0.72 | SLC6A9 (0.48) | CTSKCTSBCTSSKCNH2 | |
| SCHEMBL4573119 | 0.71 | SLC6A9 (0.40) | CTSKCTSBCTSSKCNH2MEN1 | |
| SCHEMBL4573929 | 0.69 | DRD2 (0.40) | — | |
| SCHEMBL4584329 | 0.69 | HRH3 (0.40) | KCNH2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009001127-A1 | CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS | ASTRAZENECA AB (SE) | 2008-12-31 | — | — | WO | disclosed |